Risultati della ricerca - Neeta Pandit‐Taskar

Raffina i risultati
  1. 1
    Norepinephrine Transporter as a Target for Imaging and Therapy

    Norepinephrine Transporter as a Target for Imaging and Therapy di Neeta Pandit‐Taskar, Shakeel Modak

    Pubblicazione 2017
    Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  2. 2
    Novel Tracers and Their Development for the Imaging of Metastatic Prostate Cancer

    Novel Tracers and Their Development for the Imaging of Metastatic Prostate Cancer di Andrea B. Apolo, Neeta Pandit‐Taskar, Michael J. Morris

    Pubblicazione 2008
    Testo Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  3. 3
    Bone-Seeking Radiopharmaceuticals for Treatment of Osseous Metastases, Part 1: α Therapy with <sup>223</sup>Ra-Dichloride

    Bone-Seeking Radiopharmaceuticals for Treatment of Osseous Metastases, Part 1: α Therapy with <sup>223</sup>Ra-Dichloride di Neeta Pandit‐Taskar, Steven M. Larson, Jorge A. Carrasquillo

    Pubblicazione 2013
    Testo Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  4. 4
    Radiation dosimetry of 18F-FDG PET/CT: incorporating exam-specific parameters in dose estimates

    Radiation dosimetry of 18F-FDG PET/CT: incorporating exam-specific parameters in dose estimates di Brian Quinn, Z. L. Dauer, Neeta Pandit‐Taskar, Heiko Schöder, Lawrence T. Dauer

    Pubblicazione 2016
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  5. 5
    Molecular Imaging of Biomarkers in Breast Cancer

    Molecular Imaging of Biomarkers in Breast Cancer di Gary A. Ulaner, Christopher C. Riedl, Maura N. Dickler, Komal Jhaveri, Neeta Pandit‐Taskar, Wolfgang Weber

    Pubblicazione 2016
    Testo Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  6. 6
    Patient-specific organ and effective dose estimates in pediatric oncology computed tomography

    Patient-specific organ and effective dose estimates in pediatric oncology computed tomography di Yiming Gao, Brian Quinn, Neeta Pandit‐Taskar, Gerald Behr, Usman Mahmood, D Long, Xiaobin Xu, Jean St. Germain, Lawrence T. Dauer

    Pubblicazione 2017
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  7. 7
    Key role for myeloid cells: Phase II results of anti‐G<sub>D2</sub> antibody 3F8 plus granulocyte‐macrophage colony‐stimulating factor for chemoresistant osteomedullary neuroblastoma

    Key role for myeloid cells: Phase II results of anti‐G<sub>D2</sub> antibody 3F8 plus granulocyte‐macrophage colony‐stimulating factor for chemoresistant osteomedullary neuroblasto... di Nai‐Kong V. Cheung, Irene Y. Cheung, Kim Kramer, Shakeel Modak, Deborah Kuk, Neeta Pandit‐Taskar, Elizabeth Chamberlain, Irina Ostrovnaya, Brian H. Kushner

    Pubblicazione 2014
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  8. 8
    Recurrent Ovarian Cancer: Use of Contrast-enhanced CT and PET/CT to Accurately Localize Tumor Recurrence and to Predict Patients’ Survival

    Recurrent Ovarian Cancer: Use of Contrast-enhanced CT and PET/CT to Accurately Localize Tumor Recurrence and to Predict Patients’ Survival di Evis Sala, Masako Kataoka, Neeta Pandit‐Taskar, Nicole Ishill, Svetlana Mironov, Chaya S. Moskowitz, Oleg Mironov, Michelle A. Collins, S. Dennis, Steven M. Larson, Hedvig Hricak

    Pubblicazione 2010
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  9. 9
    Feasibility and Predictability of Perioperative PET and Estrogen Receptor Ligand in Patients with Invasive Breast Cancer

    Feasibility and Predictability of Perioperative PET and Estrogen Receptor Ligand in Patients with Invasive Breast Cancer di Mary L. Gemignani, Sujata Patil, Venkatraman Seshan, Michelle Sampson, John L. Humm, Jason S. Lewis, Edi Brogi, Steven M. Larson, Monica Morrow, Neeta Pandit‐Taskar

    Pubblicazione 2013
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  10. 10
    Biodistribution and radiation dose estimates for 68Ga-DOTA-JR11 in patients with metastatic neuroendocrine tumors

    Biodistribution and radiation dose estimates for 68Ga-DOTA-JR11 in patients with metastatic neuroendocrine tumors di Simone Krebs, Neeta Pandit‐Taskar, Diane Reidy‐Lagunes, Bradley J. Beattie, Serge K. Lyashchenko, Jason S. Lewis, Lisa Bodei, Wolfgang Weber, Joseph A. O’Donoghue

    Pubblicazione 2018
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  11. 11
    Sentinel lymph node biopsy in the management of early-stage cervical carcinoma

    Sentinel lymph node biopsy in the management of early-stage cervical carcinoma di John P. Diaz, Mary L. Gemignani, Neeta Pandit‐Taskar, Kay J. Park, Melissa P. Murray, S. Dennis, Yukio Sonoda, Richard R. Barakat, Nadeem R. Abu‐Rustum

    Pubblicazione 2011
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  12. 12
    A comparison of pediatric and adult CT organ dose estimation methods

    A comparison of pediatric and adult CT organ dose estimation methods di Yiming Gao, Brian Quinn, Usman Mahmood, D Long, Yusuf E. Erdi, Jean St. Germain, Neeta Pandit‐Taskar, X. George Xu, Wesley E. Bolch, Lawrence T. Dauer

    Pubblicazione 2017
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  13. 13
    Impact of pre-operative positron emission tomography in gallbladder cancer

    Impact of pre-operative positron emission tomography in gallbladder cancer di Universe Leung, Neeta Pandit‐Taskar, Carlos U. Corvera, Michael I. D’Angelica, Peter J. Allen, T. Peter Kingham, Ronald P. DeMatteo, William R. Jarnagin, Yuman Fong

    Pubblicazione 2014
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  14. 14
    Antibody Mass Escalation Study in Patients with Castration-Resistant Prostate Cancer Using <sup>111</sup>In-J591: Lesion Detectability and Dosimetric Projections for <sup>90</sup>Y Radioimmunotherapy

    Antibody Mass Escalation Study in Patients with Castration-Resistant Prostate Cancer Using <sup>111</sup>In-J591: Lesion Detectability and Dosimetric Projections for <sup>90</sup>Y... di Neeta Pandit‐Taskar, Joseph A. O’Donoghue, Michael J. Morris, Eze A. Wills, Lawrence H. Schwartz, Mithat Gönen, Howard I. Scher, Steven M. Larson, Chaitanya Divgi

    Pubblicazione 2008
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  15. 15
    Sentinel lymph node mapping for grade 1 endometrial cancer: Is it the answer to the surgical staging dilemma?

    Sentinel lymph node mapping for grade 1 endometrial cancer: Is it the answer to the surgical staging dilemma? di Nadeem R. Abu‐Rustum, Fady Khoury‐Collado, Neeta Pandit‐Taskar, Robert A. Soslow, Fanny Dao, Yukio Sonoda, Douglas A. Levine, Carol L. Brown, S. Dennis, Richard R. Barakat, Mary L. Gemignani

    Pubblicazione 2009
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  16. 16
    Phase I Trial of Well-Differentiated Neuroendocrine Tumors (NETs) with Radiolabeled Somatostatin Antagonist 177Lu-Satoreotide Tetraxetan

    Phase I Trial of Well-Differentiated Neuroendocrine Tumors (NETs) with Radiolabeled Somatostatin Antagonist 177Lu-Satoreotide Tetraxetan di Diane Reidy‐Lagunes, Neeta Pandit‐Taskar, Joseph A. O’Donoghue, Simone Krebs, Kevin D. Staton, Serge K. Lyashchenko, Jason S. Lewis, Nitya Raj, Mithat Gönen, Christian Lohrmann, Lisa Bodei, Wolfgang Weber

    Pubblicazione 2019
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  17. 17
    Phase I Trial of Selective Internal Radiation Therapy for Chemorefractory Colorectal Cancer Liver Metastases Progressing After Hepatic Arterial Pump and Systemic Chemotherapy

    Phase I Trial of Selective Internal Radiation Therapy for Chemorefractory Colorectal Cancer Liver Metastases Progressing After Hepatic Arterial Pump and Systemic Chemotherapy di Constantinos T. Sofocleous, Alessandra R. Garcia, Neeta Pandit‐Taskar, Richard Kinh Gian, Lynn A. Brody, Elena N. Petre, Marinela Capanu, Anne P. Longing, Joanne F. Chou, Jorge A. Carrasquillo, Nancy E. Kemeny

    Pubblicazione 2013
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  18. 18
    Sequential Cytarabine and α-Particle Immunotherapy with Bismuth-213–Lintuzumab (HuM195) for Acute Myeloid Leukemia

    Sequential Cytarabine and α-Particle Immunotherapy with Bismuth-213–Lintuzumab (HuM195) for Acute Myeloid Leukemia di Todd Rosenblat, Michael R. McDevitt, Deborah Mulford, Neeta Pandit‐Taskar, Chaitanya Divgi, Katherine S. Panageas, Mark Heaney, Suzanne Chanel, Alfred Morgenstern, George Sgouros, Steven M. Larson, David A. Scheinberg, Joseph G. Jurcic

    Pubblicazione 2010
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  19. 19
    Indium 111-labeled J591 anti-PSMA antibody for vascular targeted imaging in progressive solid tumors

    Indium 111-labeled J591 anti-PSMA antibody for vascular targeted imaging in progressive solid tumors di Neeta Pandit‐Taskar, Joseph A. O’Donoghue, Chaitanya Divgi, Eze A. Wills, Lawrence H. Schwartz, Mithat Gönen, Peter Smith‐Jones, Neil H. Bander, Howard I. Scher, Steven M. Larson, Michael J. Morris

    Pubblicazione 2015
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  20. 20
    Retooling a Blood-Based Biomarker: Phase I Assessment of the High-Affinity CA19-9 Antibody HuMab-5B1 for Immuno-PET Imaging of Pancreatic Cancer

    Retooling a Blood-Based Biomarker: Phase I Assessment of the High-Affinity CA19-9 Antibody HuMab-5B1 for Immuno-PET Imaging of Pancreatic Cancer di Christian Lohrmann, Eileen M. O’Reilly, Joseph A. O’Donoghue, Neeta Pandit‐Taskar, Jorge A. Carrasquillo, Serge K. Lyashchenko, Shutian Ruan, Rebecca Teng, Wolfgang Scholz, Paul W. Maffuid, Jason S. Lewis, Wolfgang Weber

    Pubblicazione 2019
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:

Strumenti per la ricerca: